Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis submits second FDA application for CAR-T therapy Kymriah, this time in diffuse large B-cell

pharmafileNovember 01, 2017

Tag: Kymriah , CAR-T

PharmaSources Customer Service